The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Target deconvolution strategies in drug discovery
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Initial sequencing and analysis of the human genome
International Human Genome Sequencing Consortium, Whitehead Institute for Biomedical Research, C. F. G. R., Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., Devon, K., Dewar, K., et al. (2001) · Nature · doi:10.1038/35057062 · Cited by 24,216
The sequence of the human genome
Venter, J. C., Adams, M. D., Myers, E. W., Li, P. W., Mural, R. J., Sutton, G. G., Smith, H. O., Yandell, M., Evans, C. A., Holt, R. A., et al. (2001) · Science · doi:10.1126/science.1058040 · Cited by 13,909
A novel genetic system to detect protein–protein interactions
Fields, S., & Song, O.-K. (1989) · Nature · doi:10.1038/340245a0 · Cited by 6,114
Lamb, J., Crawford, E. D., Peck, D., Modell, J. W., Blat, I. C., Wrobel, M. J., Lerner, J., Brunet, J.-P., Subramanian, A., Ross, K. N., et al. (2006) · Science · doi:10.1126/science.1132939 · Cited by 5,257
Finishing the euchromatic sequence of the human genome
International Human Genome Sequencing Consortium (2004) · Nature · doi:10.1038/nature03001 · Cited by 4,971
Can the pharmaceutical industry reduce attrition rates?
Kola, I., & Landis, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1470 · Cited by 4,167
Smith, G. P. (1985) · Science · doi:10.1126/science.4001944 · Cited by 4,143
How many drug targets are there?
Overington, J. P., Al-Lazikani, B., & Hopkins, A. L. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2199 · Cited by 3,505
Printing Proteins as Microarrays for High-Throughput Function Determination
MacBeath, G., & Schreiber, S. L. (2000) · Science · doi:10.1126/science.289.5485.1760 · Cited by 2,767
A Mammalian Histone Deacetylase Related to the Yeast Transcriptional Regulator Rpd3p
Taunton, J., Hassig, C. A., & Schreiber, S. L. (1996) · Science · doi:10.1126/science.272.5260.408 · Cited by 1,829
A receptor for the immuno-suppressant FK506 is a cis–trans peptidyl-prolyl isomerase
Harding, M. W., Galat, A., Uehling, D. E., & Schreiber, S. L. (1989) · Nature · doi:10.1038/341758a0 · Cited by 1,396
Siekierka, J. J., Hung, S. H. Y., Poe, M., Lin, C. S., & Sigal, N. H. (1989) · Nature · doi:10.1038/341755a0 · Cited by 1,010
Nagar, B., Bornmann, W. G., Pellicena, P., Schindler, T. H., Veach, D. R., Miller, W. T., Clarkson, B. D., & Kuriyan, J. (2002) · PubMed · Cited by 923
Microarrays of cells expressing defined cDNAs
Ziauddin, J., & Sabatini, D. M. (2001) · Nature · doi:10.1038/35075114 · Cited by 922
A small molecule inhibitor of β-catenin/cyclic AMP response element-binding protein transcription
Emami, K. H., Nguyen, C., Ma, H., Kim, D. H., Jeong, K. W., Eguchi, M., Moon, R. T., Teo, J.-L., Oh, S. W., Kim, H. Y., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404875101 · Cited by 874
Zhu, H., & Snyder, M. (2003) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(02)00005-4 · Cited by 870
Exploiting Chemical Libraries, Structure, and Genomics in the Search for Kinase Inhibitors
Gray, N. S., Wodicka, L., Thunnissen, A.-M. W. H., Norman, T. C., Kwon, S., Espinoza, F. H., Morgan, D. O., Barnes, G., LeClerc, S., Meijer, L., et al. (1998) · Science · doi:10.1126/science.281.5376.533 · Cited by 808
Mass spectrometry and the age of the proteome
Yates, J. R. (1998) · Journal of Mass Spectrometry · doi:10.1002/(sici)1096-9888(199801)33:1<1::aid-jms624>3.0.co;2-9 · Cited by 752
Mining the Wnt pathway for cancer therapeutics
Barker, N., & Clevers, H. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2154 · Cited by 743
TOR signalling in bugs, brain and brawn
Jacinto, E., & Hall, M. N. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1018 · Cited by 565
Target-based drug discovery: is something wrong?
Sams-Dodd, F. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03316-1 · Cited by 522
An in vitro polysome display system for identifying ligands from very large peptide libraries.
Mattheakis, L. C., Bhatt, R. R., & Dower, W. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.9022 · Cited by 514
Chemogenomic profiling: Identifying the functional interactions of small molecules in yeast
Giaever, G., Flaherty, P., Kumm, J., Proctor, M., Nislow, C., Jaramillo, D. F., Chu, A. M., Jordan, M. I., Arkin, A. P., & Davis, R. W. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307490100 · Cited by 504
Sneader, W. (2005) · Wiley eBooks · doi:10.1002/0470015535 · Cited by 427
Caricasole, A., Copani, A., Caraci, F., Aronica, E., Rozemuller, A. J., Caruso, A., Storto, M., Gaviraghi, G., Terstappen, G. C., & Nicoletti, F. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1381-04.2004 · Cited by 398
Self-citationRoscovitine Targets, Protein Kinases and Pyridoxal Kinase
Bach, S., Knockaert, M., Reinhardt, J., Lozach, O., Schmitt, S., Baratte, B., Koken, M., Coburn, S. P., Tang, L., Jiang, T., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500806200 · Cited by 356
Cellular imaging in drug discovery
Lang, P., Yeow, K., Nichols, A., & Scheer, A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2008 · Cited by 351
An efficient proteomics method to identify the cellular targets of protein kinase inhibitors
Godl, K., Wissing, J., Kurtenbach, A., Habenberger, P., Blencke, S., Gutbrod, H., Salassidis, K., Stein-Gerlach, M., Missio, A., Cotten, M., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2535024100 · Cited by 336
Sneader, W. (2005) · Cited by 302
A three-hybrid system for detecting small ligand–protein receptor interactions
Licitra, E. J., & Liu, J. O. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.12817 · Cited by 299
Can cell systems biology rescue drug discovery?
Butcher, E. C. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1754 · Cited by 276
From Knowing to Controlling: A Path from Genomics to Drugs Using Small Molecule Probes
Strausberg, R. L., & Schreiber, S. L. (2003) · Science · doi:10.1126/science.1083395 · Cited by 260
Pathway Mapping Tools for Analysis of High Content Data
Ekins, S., Nikolsky, Y., Bugrim, A., Kirillov, E., & Nikolskaya, T. (2006) · High Content Screening · doi:10.1385/1-59745-217-3:319 · Cited by 255
High-performance affinity beads for identifying drug receptors
Shimizu, N., Sugimoto, K., Tang, J., Nishi, T., Sato, I., Hiramoto, M., Aizawa, S., Hatakeyama, M., Ohba, R., Hatori, H., et al. (2000) · Nature Biotechnology · doi:10.1038/78496 · Cited by 250
Huang, J., Zhu, H., Haggarty, S. J., Spring, D. R., Hwang, H., Jin, F., Snyder, M., & Schreiber, S. L. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407117101 · Cited by 245
Discovery of Novel Targets of Quinoline Drugs in the Human Purine Binding Proteome
Graves, P. R., Kwiek, J. J., Fadden, P., Ray, R., Hardeman, K., Coley, A. M., Foley, M., & Haystead, T. A. J. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.6.1364 · Cited by 239
Quantitative Chemical Proteomics for Identifying Candidate Drug Targets
Oda, Y., Owa, T., Sato, T., Boucher, B., Daniels, S., Yamanaka, H., Shinohara, Y., Yokoi, A., Kuromitsu, J., & Nagasu, T. (2003) · Analytical Chemistry · doi:10.1021/ac026196y · Cited by 190
Functional genomics to new drug targets
Kramer, R., & Cohen, D. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1552 · Cited by 170
Characterization of potent inhibitors of the Bcr-Abl and the c-kit receptor tyrosine kinases.
Wisniewski, D. J., Lambek, C. L., Liu, C., Strife, A., Veach, D. R., Nagar, B., Young, M. A., Schindler, T. H., Bornmann, W. G., Bertino, J. R., et al. (2002) · PubMed · Cited by 161
Proteomics-based Target Identification
Towbin, H., Bair, K. W., DeCaprio, J. A., Eck, M. J., Kim, S., Kinder, F. R. J., Morollo, A. A., Mueller, D. R., Schindler, P. A., Song, H. K., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m309039200 · Cited by 148
Small-molecule synergist of the Wnt/β-catenin signaling pathway
Zhang, Q., Major, M. B., Takanashi, S., Camp, N. D., Nishiya, N., Peters, E. C., Ginsberg, M. H., Jian, X., Randazzo, P. A., Schultz, P. G., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702136104 · Cited by 139
A Three-Hybrid Approach to Scanning the Proteome for Targets of Small Molecule Kinase Inhibitors
Becker, F., Murthi, K. K., Smith, C. C., Come, J. H., COSTAROLDAN, N., Kaufmann, C. M., Hanke, U., Degenhart, C., Baumann, S. W., Wallner, W., et al. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.02.001 · Cited by 139
Display cloning: functional identification of natural product receptors using cDNA-phage display
Sche, P. P., McKenzie, K. M., White, J. D., & Austin, D. J. (1999) · Chemistry & Biology · doi:10.1016/s1074-5521(00)80018-6 · Cited by 135
Wang, G., Shang, L., Burgett, A. W. G., Harran, P. G., & Wang, X. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610832104 · Cited by 133
Sato, S., Kwon, Y., Kamisuki, S., Srivastava, N., Mao, Q., Kawazoe, Y., & Uesugi, M. (2007) · Journal of the American Chemical Society · doi:10.1021/ja0655643 · Cited by 127
A Genome-Wide Overexpression Screen in Yeast for Small-Molecule Target Identification
Luesch, H., Wu, T. Y.-H., Ren, P., Gray, N. S., Schultz, P. G., & Supek, F. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.10.015 · Cited by 114
Shim, J. S., Lee, J., Park, H., Park, S. J., & Kwon, H. J. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.08.015 · Cited by 103
Complex phenotypic assays in high-throughput screening
Clemons, P. A. (2004) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2004.04.002 · Cited by 102
Chemical genetics: tailoring tools for cell biology
Mayer, T. U. (2003) · Trends in Cell Biology · doi:10.1016/s0962-8924(03)00077-1 · Cited by 101
Hammond, P. W., Alpin, J., Rise, C. E., Wright, M. C., & Kreider, B. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011641200 · Cited by 92
Li, X., Zolli‐Juran, M., Cechetto, J. D., Daigle, D. M., Wright, G. D., & Brown, E. D. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.08.014 · Cited by 92
Ligand selectivity and competition between enzymes in silico
Macchiarulo, A., Nobeli, I., & Thornton, J. M. (2004) · Nature Biotechnology · doi:10.1038/nbt999 · Cited by 89
Peterson, J. R., Lebensohn, A. M., Pelish, H. E., & Kirschner, M. W. (2006) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.02.009 · Cited by 85
Drug Receptor Identification from Multiple Tissues Using Cellular-Derived mRNA Display Libraries
McPherson, M., Yang, Y., Hammond, P. W., & Kreider, B. L. (2002) · Chemistry & Biology · doi:10.1016/s1074-5521(02)00148-5 · Cited by 64
Guiffant, D., Tribouillard‐Tanvier, D., Gug, F., Galons, H., Meijer, L., Blondel, M., & Bach, S. (2007) · Biotechnology Journal · doi:10.1002/biot.200600223 · Cited by 59
A versatile method of identifying specific binding proteins on affinity resins
Yamamoto, K., Yamazaki, A., Takeuchi, M., & Tanaka, A. (2006) · Analytical Biochemistry · doi:10.1016/j.ab.2006.02.008 · Cited by 56
Shiyama, T., Furuya, M., Yamazaki, A., Terada, T., & Tanaka, A. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.03.052 · Cited by 53
Annotating the human proteome: Beyond establishing a parts list
Mueller, M., Martens, L., & Apweiler, R. (2006) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2006.11.011 · Cited by 37
Chemical genetic approaches to probing cell death
Gangadhar, N. M., & Stockwell, B. R. (2006) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2006.11.033 · Cited by 31
Rossenu, S., Dewitte, D., Vandekerckhove, J. S., & Ampè, C. (1997) · Journal of Protein Chemistry · doi:10.1023/a:1026317612554 · Cited by 26
High Throughput Scintillation Proximity Assay for the Identification of FKBP-12 Ligands
Graziani, F., Aldegheri, L., & Terstappen, G. C. (1999) · SLAS DISCOVERY · doi:10.1177/108705719900400102 · Cited by 22
Self-citationRethinking Target Discovery in Polygenic Diseases
Flordellis, C. S., Manolis, A. S., Paris, H., & Karabinis, A. (2006) · Current Topics in Medicinal Chemistry · doi:10.2174/156802606778194226 · Cited by 19
Cited by
Chalcone: A Privileged Structure in Medicinal Chemistry
Zhuang, C., Zhang, W., Sheng, C., Zhang, W., Xing, C., & Miao, Z. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00020 · Cited by 1,463
The spectrum of latent tuberculosis: rethinking the biology and intervention strategies
Barry, C. E., Boshoff, H. I., Dartois, V., Dick, T., Ehrt, S., Flynn, J., Schnappinger, D., Wilkinson, R. J., & Young, D. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2236 · Cited by 1,422
Natural product discovery: past, present, and future
Katz, L., & Baltz, R. H. (2016) · Journal of Industrial Microbiology and Biotechnology · doi:10.1007/s10295-015-1723-5 · Cited by 1,144
Target identification and mechanism of action in chemical biology and drug discovery
Schenone, M., Dančík, V., Wagner, B. K., & Clemons, P. A. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1199 · Cited by 1,096
Target identification using drug affinity responsive target stability (DARTS)
Lomenick, B., Hao, R., Jonai, N., Chin, R. M., Aghajan, M., Warburton, S., Wang, J., Wu, R. P., Gomez, F., Loo, J. A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910040106 · Cited by 1,095
Metadata
- Authors
- Terstappen, G. C., Schlüpen, C., Raggiaschi, R., & Gaviraghi, G.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2007-11
- Volume
- 6
- Issue
- 11
- Pages
- 891-903
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1991820123
- Cited by
- 429
- References
- 62
- FWCI
- 1.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.